Award Description

This award recognizes a BIOTECanada member company that has distinguished itself through its contributions to the community or communities in Canada beyond its normal business activities. The company will have demonstrated leadership through involvement in local, regional or national efforts and shown significant commitment in contributing to organizations, schools, or activities.  The company will have established a solid foundation of social responsibility and demonstrated continued commitment in Canada.
 
A variety of approaches can be recognized from establishing learning programs, donating goods and services, supporting employee volunteering, to supporting charity and community events. It will have developed or continued partnerships during the year that has allowed the company to be recognized as a leader and an important part of the local or national community.  
 
The award has been established to showcase the contributions member companies offer to our Canadian quality of life beyond their respective business and economic impact.  This award is based on performance in the previous calendar year (2011).

---

Sanofi Pasteur Limited - 2011 Contribution to Canadian Communities Winner

For over 95 years, sanofi pasteur has protected Canadians and people around the world against vaccine preventable diseases such as diphtheria, tetanus, polio and pertussis.  Founded in 1914 as Connaught Laboratories, sanofi pasteur continues to research, develop and manufacture vaccines in Canada for domestic and international markets. The Connaught campus is home to more than 1,100 employees, and is a centre for global manufacturing and R&D. Every year, approximately 50 million doses of vaccine are produced in Toronto and shipped to more than 90 countries.  Major products manufactured at the Toronto site include five-component pertussis containing vaccines such as Pediacel, Adacel and Quadracel.

Sanofi Pasteur is the vaccines division of the sanofi-aventis Group, a diversified global healthcare company engaged in the research, development, manufacture and marketing of healthcare products.  The sanofi-aventis Group in Canada annually spends over $180 million on R&D, making it the top R&D investor in the country for the innovative pharmaceutical industry and the 12th largest private sector investor overall.  Sanofi pasteur invests approximately $100 million in Canadian vaccine R&D each year, including a new $101 million R&D facility that opened in 2010, which is now home to the North American “Centre of Excellence” for Bioprocess and Analytical R&D.

Sanofi Pasteur is proud to go beyond producing quality vaccines to promoting and creating healthy communities. Our activities span a variety of initiatives such as inspiring students through the Sanofi-Aventis BioTalent Challenge, respecting the environment, supporting employees in causes that matter to them and donating vaccines to developing countries. The company is a major sponsor of the United Way as well as other charitable organizations.